San Fransisco, CA– “The Father of Cannabis Research” Raphael Mechoulam will be honored with a Lifetime Achievement Award and a $10,000 research grant from The Arcview Group in their first annual cannabis awards.
As explained in a press release from Arcview, Mechoulam is the person responsible for isolating cannabinoids, which led to the discoveries of the endocannabinoid system (ECS) and the total synthesis of cannabinoids in the cannabis plant. He is being recognized for his “cutting-edge cannabis research and breakthrough discovery of THC, one of at least 113 cannabinoids identified in the cannabis plant.” Arcview also announced that it is naming future recipients of this award the “Arcview Raphael Mechoulam Lifetime Achievement Award.”
“Cannabis research has never been more critical to the future of our industry, especially as the federal government begins processing dozens of pending applications for the steps necessary to improve access to marijuana research,” Troy Dayton, CEO and co-founder of The Arcview Group, said in the release. “As the first person to synthesize THC, identify the endocannabinoid system and illustrate the medicinal properties of cannabis, no one is more deserving than Raphael of our Lifetime Achievement Award. We can’t wait to see what he uncovers next.”
Related:Phytocannabinoids: 25 Things to Know Now
Raphael Mechoulam Receives ABC Norman R. Farnsworth Excellence in Botanical Research Award
The Healing Power of the Endocannabinoid System (ECS) (Podcast)
The honors will be presented at the Arcview Investor Forum: The Evolution of Cannabis: 2020 in New York on October 3, 2019.